ClassID:

113517

C12Y102/01012 - CPC Classification

Classification description:

Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with NAD+ or NADP+ as acceptor (1.2.1) Glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) (1.2.1.12)

Recent Application in this class:
#1
20260146255
2026-05-28

MODULATION OF NADPH GENERATION BY RECOMBINANT YEAST HOST CELL DURING FERMENTATION

#2
20260117264
2026-04-30

GENETICALLY ENGINEERED MICROBE FOR PRODUCTION OF ISOPRENE FROM A CARBON SOURCE AND METHOD OF PRODUCTION THEREOF

#3
20260107949
2026-04-23

METARHIZIUM PINGSHAENSE STRAIN FOR CONTROLLING SOLENOPSIS INVICTA, AND ENGINEERED STRAIN AND USE THEREOF

#4
20260035705
2026-02-05

ENGINEERED MICROORGANISMS WITH G3P ->3PG ENZYME AND/OR FRUCTOSE-1,6-BISPHOSPHATASE INCLUDING THOSE HAVING SYNTHETIC OR ENHANCED METHYLOTROPHY

#5
20250340828
2025-11-06

MICROORGANISM AND METHOD FOR THE IMPROVED PRODUCTION OF LEUCINE AND/OR ISOLEUCINE

#6
20250197842
2025-06-19

IMPROVING ENZYMATIC CHANNELING EFFICIENCY VIA MIXED NANOPARTICLE SCAFFOLDS WITHIN SELF-ASSEMBLED NANOPARTICLE ENZYME CLUSTERS

#7
20250027125
2025-01-23

CORYNEBACTERIUM GLUTAMICUM VARIANT HAVING IMPROVED L-LYSINE PRODUCTION ABILITY AND METHOD FOR PRODUCING L-LYSINE BY USING SAME

#8
20240293543
2024-09-05

ENGINEERED CELLS FOR THERAPY

#9
20240191209
2024-06-13

VACCINE FOR IMMUNOCOMPROMISED HOSTS

#10
20240067997
2024-02-29

GENOMIC ENGINEERING OF BIOSYNTHETIC PATHWAYS LEADING TO INCREASED NADPH

#11
20240060047
2024-02-22

CELLS WITH SUSTAINED TRANSGENE EXPRESSION

#12
20240026311
2024-01-25

ARTIFICIALLY SYNTHESIZED mRNA AND USE OF SAME

#13
20240026280
2024-01-25

PLASMID ADDICTION SYSTEMS

#14
20230340077
2023-10-26

PRODUCTION OF MYOGLOBIN FROM TRICHODERMA USING A FEEDING MEDIA

#15
20230272438
2023-08-31

COMPOSITIONS, SYSTEMS, AND METHODS FOR ARTIFICIAL CARBON FIXATION, CHEMICAL SYNTHESIS, AND/OR PRODUCTION OF USEFUL PRODUCTS

#16
20230272391
2023-08-31

ADAR DEPENDENT EDITING COMPOSITIONS AND METHODS OF USE THEREOF

#17
20230080865
2023-03-16

CHIMERIC RECOMBINANT PROTEIN ENCODING EPITOPES WITH IDENTITY TO BACTERIAL, FUNGAL, PARASITE AND HUMAN METABOLIC ENZYMES INVOLVED IN PATHOGENESIS DURING SEXUALLY TRANSMITTED INFECTIONS

#18
20220409739
2022-12-29

AN EXTRACELLULAR VESICLE

#19
20220348973
2022-11-03

Method for producing L-amino acids using microorganism containing NADP-dependent glyceraldehyde-3-phosphate dehydrogenase

#20
20220325288
2022-10-13

Gold Optimized CAR Natural Killer cells

#21
20220259608
2022-08-18

Promoter variants for protein production

#22
20220228156
2022-07-21

Gold Optimized CAR T-cells

#23
20220204977
2022-06-30

Gold optimized CAR T-cells

#24
20220186233
2022-06-16

Gold optimized CAR t-cells

#25
20220177895
2022-06-09

Engineered microorganisms with G3P → 3PG enzyme and/or fructose-1,6-bisphosphatase including those having synthetic or enhanced methylotrophy

#26
20220064685
2022-03-03

BIOSYNTHETIC METHODS AND SYSTEMS FOR PRODUCING MONOSACCHARIDES

#27
20220049229
2022-02-17

Vaccine for immunocompromised hosts

#28
20210380989
2021-12-09

MODULATION OF NADPH GENERATION BY RECOMBINANT YEAST HOST CELL DURING FERMENTATION

#29
20210292771
2021-09-23

Gold Optimized CAR T-cells

#30
20200385741
2020-12-10

Gold Optimized CAR T-cells

#31
20200354725
2020-11-12

Gold optimized CAR T-cells

#32
20200354724
2020-11-12

Gold Optimized CAR T-cells

#33
20200263214
2020-08-20

Genomic engineering of biosynthetic pathways leading to increased NADPH

#34
20200209244
2020-07-02

Tumor blood marker, use thereof, and kit comprising the same

#35
20200181629
2020-06-11

YEAST EXPRESSING A SYNTHETIC CALVIN CYCLE

#36
20200131520
2020-04-30

Gold optimized CAR T-cells

#37
20200032273
2020-01-30

Gold optimized CAR T-cells

#38
20190330666
2019-10-31

Self-assembled nanoplatelet-enzyme bioconjugates providing for increased biocatalytic efficiency

#39
20190309310
2019-10-10

Gold optimized CAR T-cells

#40
20190290724
2019-09-26

COMPOSITIONS AND USES THEREOF

#41
20190264239
2019-08-29

Molecular rheostat for cofactor balance

#42
20190185866
2019-06-20

Methods of producing promoter variants

#43
20190024095
2019-01-24

Gold optimized CAR T-cells

#44
20190022191
2019-01-24

Mutant glyceraldehyde-3-phosphate dehydrogenase (GAPDH) compositions and methods of treating cancer

#45
20180282816
2018-10-04

Methods for determining the metabolic status of lymphomas

#46
20180171325
2018-06-21

Nanoparticle-attached enzyme cascades for accelerated multistep biocatalysis

#47
20180113129
2018-04-26

Measuring GAPDH protein for diagnosis and treatment of alzheimer's disease

#48
20180057822
2018-03-01

Gold optimized CAR T-cells

#49
20180024129
2018-01-25

Lateral flow device and method of use

#50
20170253889
2017-09-07

Promoter and regulatory elements for improved expression of heterologous genes in host cells

#51
20170198315
2017-07-13

Methods for efficient production of polyunsaturated fatty acids (PUFA) in and species

#52
20170191040
2017-07-06

Vaccine for immunocompromised hosts

#53
20170159058
2017-06-08

CELL-FREE SYSTEM FOR CONVERTING METHANE INTO FUEL AND CHEMICAL COMPOUNDS

#54
20170037418
2017-02-09

Regulatable promoter

#55
20160376613
2016-12-29

Glycerol 3-phosphate dehydrogenase for butanol production

#56
20160340698
2016-11-24

Genetically engineered yeast cell having increased NADPH production, method of increasing NADPH level in yeast cell, method of preparing yeast cell, and method of producing lactate using yeast cell

#57
20150225791
2015-08-13

BIOMARKER FOR VASCULAR ENDOTHELIAL FUNCTION

#58
20150152447
2015-06-04

YEAST CELL WITH INACTIVATED GLYCEROL-3-PHOSPHATE DEHYDROGENASE AND ACTIVATED GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE AND METHOD OF PRODUCING LACTATE USING THE SAME

#59
20140286926
2014-09-25

METHOD FOR TREATMENT OR PREVENTION OF ALLERGIC DISEASES

#60
20140186430
2014-07-03

Cochleate compositions directed against expression of proteins

#61
20140037690
2014-02-06

Anti-allergic substance, anti-allergic agent, and food

#62
20130273555
2013-10-17

Detoxification of biomass derived acetate via metabolic conversion to ethanol, acetone, isopropanol, or ethyl acetate

#63
20120282322
2012-11-08

Cochleate compositions directed against expression of proteins

#64
20110091523
2011-04-21

Cochleate compositions directed against expression of proteins

#65
20100221789
2010-09-02

High potency siRNAS for reducing the expression of target genes

#66
20100159591
2010-06-24

Methods and compositions concerning siRNA's as mediators of RNA interference

#67
20090055100
2009-02-26

METHOD FOR IDENTIFYING AND/OR CHARACTERIZING A (POLY)PEPTIDE

#68
20080242625
2008-10-02

Nucleotide-Cochleate Compositions And Methods Of Use

#69
20080009457
2008-01-10

Cochleate compositions directed against expression of proteins

#70
20060148039
2006-07-06

Methylotrophic yeast producing mammalian type sugar chain

#71
20060142228
2006-06-29

Methods and compositions concerning siRNA's as mediators of RNA interference

#72
20050013855
2005-01-20

Cochleate compositions directed against expression of proteins